Stocks
CTT Pharmaceutical Holdings, Inc.CTTH
OQBHealthcareBiotechnology$0.06
Price as of · delayed, not real-time
A development-stage biopharmaceutical company focused on innovative therapies for oncology and infectious diseases, with a pipeline built around its proprietary Cell-in-a-Box technology. The company has no approved products and relies on partnerships and capital raises to fund clinical trials, making it a speculative small-cap play for investors tracking emerging drug delivery platforms.
52W Range: $0.04-$0.10
Congressional Interest in CTT Pharmaceutical Holdings, Inc. (CTTH)
No congressional trades have been disclosed for CTT Pharmaceutical Holdings, Inc. (CTTH) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading CTTH?
No congressional trades found for this stock.